NVAX
Novavax Inc
10.80$
+4.0%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 48.9% | 448.7% | 1,549.8% | 540.3% | 506.9% | 610.0% | 157.1% | 1.1% | 56.5% | 61.8% | 29.7% | 6.3% | |
| 51.1% | -348.7% | -1,449.8% | 100.0% | 100.0% | -510.0% | 100.0% | 100.0% | 43.5% | 38.2% | 70.3% | 93.7% | |
| 259.1% | 448.7% | 1,549.8% | 540.3% | 506.9% | 610.0% | 157.1% | 221.1% | 77.3% | 132.6% | 57.3% | 30.0% | |
| 65.0% | 85.1% | 303.0% | 110.5% | 100.4% | 184.4% | 30.5% | 26.0% | 30.6% | 85.4% | 49.4% | 14.0% | |
| 324.1% | 533.8% | 1,852.8% | 650.8% | 607.2% | 794.4% | 187.6% | 247.1% | 83.9% | 140.0% | 106.8% | 43.5% | |
| -273.0% | -433.8% | -1,752.8% | -550.8% | -507.2% | -646.1% | -87.6% | -147.1% | -40.3% | -101.8% | -36.5% | 50.1% | |
| 0.5% | 0.7% | 84.4% | 45.1% | 35.5% | 72.9% | 3.2% | 1.8% | 1.2% | 2.6% | 2.9% | 2.0% | |
| -270.5% | -432.9% | -1,823.5% | -589.5% | -538.8% | -711.0% | -87.9% | -149.6% | -40.9% | -97.6% | -25.9% | 39.4% | |
| -16.9% | -17.7% | 15.1% | 7.4% | 4.0% | -13.9% | 1.9% | 2.5% | 0.3% | 0.4% | 1.6% | 0.2% | |
| -270.5% | -432.9% | -1,823.5% | -589.5% | -538.8% | -697.1% | -89.9% | -152.1% | -41.1% | -98.0% | -27.5% | 39.2% | |
| -255.6% | -417.2% | -1,697.4% | -519.3% | -483.4% | -607.0% | -86.6% | -146.0% | -37.8% | -87.6% | -15.8% | 43.8% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.